Information Provided By: 
Fly News Breaks for January 13, 2020
OGI
Jan 13, 2020 | 09:12 EDT
BofA analyst Chris Carey initiated coverage of Organigram with an Underperform rating and C$2.50 price target. While he sees "a number of positives" at the company, he is being selective in his coverage of the nine cannabis stocks he rates, stating that his preference is for companies with robust balance sheets and "some control over their nearer-term destiny." The analyst added that his rating is not a call on fiscal Q1 results to be reported Tuesday, but is reflective of view on Organigram's setup for 2020.
News For OGI From the Last 2 Days
There are no results for your query OGI
